{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:12:33Z","timestamp":1790115153020,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.pnpbp.2010.02.019","type":"journal-article","created":{"date-parts":[[2010,2,25]],"date-time":"2010-02-25T10:46:25Z","timestamp":1267094785000},"page":"1342-1344","source":"Crossref","is-referenced-by-count":74,"title":["Hyperprolactinaemia in early psychosis\u2014not only due to antipsychotics"],"prefix":"10.1016","volume":"34","author":[{"given":"Jacqueline","family":"Aston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Rechsteiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Bull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Borgwardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Gschwandtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Riecher-R\u00f6ssler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2010.02.019_bib1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000012323","article-title":"Psychological stress and neuroendocrine function in humans: the last two decades of research","volume":"68","author":"Biondi","year":"1999","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.pnpbp.2010.02.019_bib2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1177\/0269881107078281","article-title":"Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics","volume":"21","author":"Bushe","year":"2007","journal-title":"J Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2010.02.019_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/0269881107088435","article-title":"A review of the association between antipsychotic use and hyperprolactinaemia","volume":"22","author":"Bushe","year":"2008","journal-title":"J Psychopharmacol."},{"issue":"Suppl 3","key":"10.1016\/j.pnpbp.2010.02.019_bib4","first-page":"10","article-title":"Hormonal side effects in women: typical versus atypical antipsychotic treatment","volume":"61","author":"Dickson","year":"2000","journal-title":"J Clin Psychiatry."},{"key":"10.1016\/j.pnpbp.2010.02.019_bib5","series-title":"\u00d6strogene beim Menschen","first-page":"461","article-title":"Psychiatrische und neurologische Erkrankungen","author":"Diczfalusy","year":"1961"},{"key":"10.1016\/j.pnpbp.2010.02.019_bib6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.biopsych.2005.04.018","article-title":"Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis","volume":"58","author":"Garner","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.02.019_bib7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2826.2008.01736.x","article-title":"Prolactin: a pleiotropic neuroendocrine hormone","volume":"20","author":"Grattan","year":"2008","journal-title":"J Neuroendocrinol."},{"key":"10.1016\/j.pnpbp.2010.02.019_bib8","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2165\/00003495-200464200-00003","article-title":"Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management","volume":"64","author":"Haddad","year":"2004","journal-title":"Drugs."},{"key":"10.1016\/j.pnpbp.2010.02.019_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1192\/bjp.bp.106.023671","article-title":"Risk of hip fracture in patients with a history of schizophrenia","volume":"190","author":"Howard","year":"2007","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.02.019_bib10","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1016\/j.pnpbp.2010.02.019_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0306-4530(02)00127-0","article-title":"Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone","volume":"28","author":"Kinon","year":"2003","journal-title":"Psychoneuroendocrinology."},{"key":"10.1016\/j.pnpbp.2010.02.019_bib12","series-title":"Psychiatrie","author":"Kraepelin","year":"1909"},{"key":"10.1016\/j.pnpbp.2010.02.019_bib13","series-title":"Untersuchungen zum Konstitutionsproblem und zur Lehre von den Temperamenten","article-title":"K\u00f6rperbau und Charakter","author":"Kretschmer","year":"1921"},{"key":"10.1016\/j.pnpbp.2010.02.019_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.schres.2007.01.022","article-title":"Effect of antipsychotics on pituitary gland volume in treatment-naive first-episode schizophrenia: a pilot study","volume":"92","author":"MacMaster","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2010.02.019_bib15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0006-3223(96)00222-3","article-title":"Recent life stressors and biological markers in newly admitted psychotic patients","volume":"41","author":"Mazure","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2010.02.019_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/schbul\/13.1.77","article-title":"Biological studies in schizophrenia","volume":"13","author":"Meltzer","year":"1987","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2010.02.019_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1017\/S1092852900002340","article-title":"Management of hyperprolactinemia in patients receiving antipsychotics","volume":"9","author":"Miller","year":"2004","journal-title":"CNS Spectr."},{"key":"10.1016\/j.pnpbp.2010.02.019_bib18","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.psyneuen.2008.05.010","article-title":"Pituitary volume in unaffected relatives of patients with schizophrenia and bipolar disorder","volume":"33","author":"Mondelli","year":"2008","journal-title":"Psychoneuroendocrinology."},{"issue":"Suppl 2","key":"10.1016\/j.pnpbp.2010.02.019_bib19","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.euroneuro.2008.02.004","article-title":"Prolactin awareness: an essential consideration for physical health in schizophrenia","volume":"18","author":"Montejo","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2010.02.019_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.jcp.0000150223.31007.e0","article-title":"Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?","volume":"25","author":"O'Keane","year":"2005","journal-title":"J Clin Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2010.02.019_bib21","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1038\/sj.npp.1300766","article-title":"Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study","volume":"30","author":"Pariante","year":"2005","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.pnpbp.2010.02.019_bib28","series-title":"Estrogen effects in psychiatric disorders","first-page":"31","article-title":"Estrogens and schizophrenia","author":"Riecher-R\u00f6ssler","year":"2005"},{"key":"10.1016\/j.pnpbp.2010.02.019_bib22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02190244","article-title":"Schizophrenia and oestrogens\u2014is there an association?","volume":"242","author":"Riecher-R\u00f6ssler","year":"1993","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2010.02.019_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s007370050002","article-title":"Gonadal function and its influence on psychopathology. A comparison of schizophrenic and non-schizophrenic female inpatients","volume":"1","author":"Riecher-R\u00f6ssler","year":"1998","journal-title":"Arch Women's Ment Health"},{"key":"10.1016\/j.pnpbp.2010.02.019_bib23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0447.2006.00854.x","article-title":"The Basel early-detection-of-psychosis (FEPSY)-study\u2014design and preliminary results","volume":"115","author":"Riecher-R\u00f6ssler","year":"2007","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2010.02.019_bib24","first-page":"71","article-title":"Antipsychotics and hyperpolactinaemia: pathophysiology, clinical relevance, diagnosis and therapy","volume":"23","author":"Riecher-R\u00f6ssler","year":"2009","journal-title":"Neuropsychiatr."},{"key":"10.1016\/j.pnpbp.2010.02.019_bib26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.psychres.2004.01.010","article-title":"Serum prolactin levels in unmedicated first-episode and recurrent schizophrenia patients: a possible marker for the disease's subtypes","volume":"127","author":"Segal","year":"2004","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2010.02.019_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1192\/S0007125000297602","article-title":"Prediction of psychosis. A step towards indicated prevention of schizophrenia","volume":"172","author":"Yung","year":"1998","journal-title":"Br J Psychiatry Suppl"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584610000667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584610000667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,26]],"date-time":"2019-05-26T11:35:56Z","timestamp":1558870556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584610000667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0278584610000667"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2010.02.019","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}